Acetylsalicylic acid Recruiting Phase 3 Trials for Peripheral Arterial Disease (PAD) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02217501Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities